Detalhe da pesquisa
1.
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
Clin Infect Dis
; 76(3): e439-e449, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608504
2.
Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population.
Emerg Infect Dis
; 29(9): 1925-1928, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37579513
3.
Prioritizing interventions for preventing COVID-19 outbreaks in military basic training.
PLoS Comput Biol
; 18(10): e1010489, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206315
4.
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.
Clin Infect Dis
; 74(5): 897-900, 2022 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117878
5.
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
Emerg Infect Dis
; 28(4): 828-832, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35203111
6.
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.
J Infect Dis
; 224(9): 1462-1472, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331541
7.
Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.
J Infect Dis
; 224(12): 2010-2019, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673956
8.
Metagenomic analysis reveals Culex mosquito virome diversity and Japanese encephalitis genotype V in the Republic of Korea.
Mol Ecol
; 30(21): 5470-5487, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34418188
9.
Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera.
bioRxiv
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712124
10.
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-up.
PLoS One
; 19(4): e0297481, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626117
11.
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
JAMA Netw Open
; 6(1): e2251360, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652247
12.
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms.
PLoS One
; 18(2): e0281272, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36757946
13.
Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study.
Open Forum Infect Dis
; 10(12): ofad579, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38130596
14.
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health.
Open Forum Infect Dis
; 9(7): ofac275, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35873301
15.
Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers.
Open Forum Infect Dis
; 9(1): ofab575, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35047649
16.
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection.
Open Forum Infect Dis
; 9(3): ofab623, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141345
17.
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies.
Sci Transl Med
; 14(645): eabn8543, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380448
18.
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
PLoS One
; 17(10): e0276241, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251675
19.
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection.
Open Forum Infect Dis
; 9(7): ofac314, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35899278
20.
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history.
Cell Host Microbe
; 30(12): 1745-1758.e7, 2022 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356586